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Abstract: Whereas brachial blood pressure (BP) is still considered the gold standard for the estimation of cardiovascular 
risk in all clinical trials and guidelines, scientific interest is shifting towards central hemodynamics and the scientific 
community is experiencing a whole new revolution with the emergence of novel cardiovascular markers such as the am-
bulatory measurement of central BP and arterial stiffness. Central BP has already started to demonstrate its superiority 
over peripheral BP as a better and more reliable predictor of end-organ damage in cardiovascular diseases. Furthermore, 
ambulatory measurement of central BP and pulse wave velocity are expected to add much more useful information to-
wards a more integrated assessment of cardiovascular risk and profile. However, more research is required before these 
novel markers could be incorporated in the everyday practice of BP measurement.  
Keywords: Ambulatory monitoring, arterial stiffness, cardiovascular risk, central blood pressure, pulse wave velocity. 
INTRODUCTION 
 Cardiovascular disease is the leading cause of death 
worldwide and hypertension is a major risk factor. Although 
cardiovascular medicine has presented novelties in the thera-
peutic field, brachial blood pressure (BP) is still considered 
the gold standard for screening, diagnosis and management 
of arterial hypertension and peripheral BP is still used as a 
major determinant of cardiovascular risk in clinical trials.  
 However, in the recent years central hemodynamics, 
namely central Systolic (cSBP) and Diastolic blood pressure 
(cDBP), pulse pressure (PP) and measurement of arterial 
stiffness, have emerged as novel parameters of cardiovascu-
lar risk, mortality and target organ damage in essential hy-
pertension (EH). As a result, new devices have been in-
vented, shifting cardiovascular research from a peripheral to 
a more central level. In that sense, ambulatory measurement 
of arterial stiffness and central blood pressure (cBP) could 
provide useful information over and above the usual meas-
urements used in the everyday clinical practice. 
PATHOPHYSIOLOGY AND MEASUREMENT OF 
ARTERIAL STIFFNESS 
 Arterial stiffness describes a non-compliant artery that is 
a vessel unable to distend in response to different pressure 
changes. The two major determinants of arterial stiffness are 
arterial hypertension and aging. Their etiologic relationship 
resides in the structural and functional alterations that they 
provoke to the arterial wall, including smooth muscle  
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hypertrophy, increased collagen deposition, degradation of 
elastic fibers and endothelial dysfunction [1-5]. 
 The pathophysiological substrate of arterial stiffness lies 
on the velocity with which pulse wave travels along the arte-
rial tree and the interrelationship between the incident and 
the reflected wave of the pressure waveform. Every time the 
heart beats a systole, an incident pulse wave generates at the 
junction with the aorta and propagates along the arterial tree. 
Propagation continues unimpeded until the pulse wave meets 
areas of discontinuity of the arterial wall, mainly the high 
resistance arterioles, thus generating a reflected wave [6]. In 
normal, healthy and young individuals where arteries are 
elastic and compliant, the reflected wave travels back to-
wards the aorta and meets the oncoming incident wave dur-
ing the early diastole thereby increasing diastolic pressure 
and facilitating coronary perfusion. However, in adults older 
than 50 years old and in elderly people, where aging and 
hypertension progressively stiffen the arteries, a different 
pattern of circulation exists. The incident wave is reflected in 
a much earlier point of the arterial tree and its reflected 
waveform travels much faster along the hardened arterial 
wall in a way that coincides with the oncoming incident 
wave during systole. The net result is augmentation of the 
cSBP and reduction of the diastolic pressure compromising 
the perfusion of the coronary arteries. At the same time, sys-
tolic hypertension increases the afterload of the heart thereby 
producing left ventricular hypertrophy and in the long term, 
heart dysfunction [7-12]. Furthermore, increased arterial 
stiffness is associated with progressive microvascular dam-
age which compromises renal and cerebral function [13, 14].  
 The velocity at which the pulse wave travels along the 
arterial tree is the most direct marker of arterial stiffness and 
has been established as the gold standard for its measure-
ment. The most common technique consists of measuring the 
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distance that a pulse wave covers between two steady body 
points (carotid and femoral artery) divided by the time 
needed to reach these sites under simultaneous electrocar-
diographic monitoring [15]. The selected arteries provide the 
advantage of a superficial, easy to access location whereas 
in-between them, lies almost the whole of the aorta which is 
the major vessel subject to arterial stiffening. In that Sense, 
pulse wave velocity (PWV) is a simple, non-invasive, repro-
ducible technique and several lines of evidence have proved 
its significance as an independent prognostic factor of car-
diovascular morbidity and mortality in patients with hyper-
tension, diabetes mellitus type II, end-stage renal disease as 
well as in the general population [16-25]. The aforemen-
tioned value has established PWV as a marker of subclinical 
organ damage according to the latest guidelines of the Euro-
pean Society of Hypertension and European Society of Car-
diology [26].  
 Despite the important relationship of arterial stiffness 
and PWV with significant hemodynamic components of the 
central arteries, paradoxically little research had been done 
so far in the field of cBP parameters. 
FROM PERIPHERAL TO CENTRAL BP 
 Peripheral BP measurement has for long been and still is 
the established technique for evaluating arterial hypertension 
and cardiovascular risk, although we know that differences 
between peripheral and cBP exist.  
 In young healthy subjects cBP is lower compared to pe-
ripheral BP due to a physiological phenomenon called PP 
amplification. At this age, PP travels from the central, elastic 
arteries towards the smaller, muscular and more resistant 
arteries of the periphery thereby undergoing an augmentation 
of its amplitude. As a result, brachial BP can be as high as 
30mmHg more compared to cBP. On the other hand, by ag-
ing the opposite effect is observed. Central arteries become 
stiffer and cSBP increases at a level higher than that of the 
periphery due to the magnitude of the reflected waves arriv-
ing at the heart. In addition, cBP represents more closely and 
more realistically the true load of the left ventricle because 
of its proximity to the key organs, including the heart [11, 
27-32]. Taking these two factors into account, someone can 
conclude that the measurement of brachial BP in an elderly 
individual may not represent the true “hypertensive” load 
and his total cardiovascular risk because the central burden 
that strains his heart may be even larger. 
 The notion that cBP represents the true load of the heart 
pump and consequently the real cardiovascular risk, has been 
the epicenter of interest of a growing number of trials. As a 
matter of fact, much research has focused lately on demon-
strating whether central arterial pressure could turn out to be 
a better marker of target organ damage and whether it could 
provide more reliable information regarding cardiovascular 
risk assessment. The first studies to be conducted, included 
patients with end-stage renal disease and indeed, underlined 
the role of cBP parameters in predicting all-cause mortality 
[33-35]. Since then, accumulating scientific evidence has 
proved that cBP can predict better cardiovascular events and 
can actually be an independent factor of cardiovascular mor-
bidity and mortality [36-43]. Furthermore, it has been shown 
that different anti-hypertensive drugs may exert similar im-
pact on peripheral BP whereas on the other hand, achieve 
different levels of cBP reduction [44-51]. Interestingly, vari-
ous reductions in cBP resulted in different cardiovascular 
outcomes, an observation that further highlights the role of 
cBP as a better marker of target organ damage and cardio-
vascular risk [42, 45, 52].  
 Since accumulating evidence points towards a greater 
necessity for assessing the central hemodynamics, newer, 
non-invasive techniques for approaching these phenomena 
have emerged. Apart from piezo-electronic techniques 
(Complior) and tonometric methods (SphygmoCor), the re-
cent advent of oscillometric devices (Arteriograph, Mobil-o-
graph) has offered the opportunity to measure peripheral and 
cBP parameters, including 24h monitoring of their variability 
[53, 54].  
SIGNIFICANCE OF 24H AMBULATORY MEAS-
UREMENT OF ARTERIAL STIFFNESS AND CEN-
TRAL BLOOD PRESSURE 
 Although research in cardiovascular field has started to 
demonstrate the superiority of central over peripheral BP, 
there are characteristics not fully investigated yet, including 
cBP and PWV variability. In this context, since peripheral 
BP levels present a circadian rhythm during the day, it 
seemed reasonable that a similar pattern for cBP and PWV 
could exist. However, almost all trials conducted so far in-
cluded BP measurements at resting conditions whereas vari-
ability of PWV has never been studied before.  
 The study by Luzardo et al. was one of the first attempts 
to assess ambulatory cBP and arterial stiffness parameters. 
The investigators enrolled 115 volunteers between 28 and 64 
years old from their working enviroment. Although they 
were not a representative sample of the general population, 
the volunteers underwent tonometric and oscillometric 
measurements of arterial stiffness and cBP parameters under 
resting and ambulatory conditions. Measurements were per-
formed using the validated Sphygmocor and Mobil-O-graph 
devices. Despite slight differences between cPP and PWV 
values among the two methods, the investigators proved that 
ambulatory, non-invasive measurement of cBP is a feasible 
procedure. Nevertheless, the study focused on comparing the 
values recorded between a tonometric and an oscillometric 
device and did not correlate possible diurnal changes of cBP 
to the established changes of peripheral BP. In addition, the 
ambulatory measurement of cBP did not include early morn-
ing and late night measurements, two time periods where the 
most important pathophysiologic alterations in peripheral BP 
take place [55]. 
 More recently, Williams and his colleagues conducted 
the first multicenter, randomized, controlled, clinical trial in 
order to assess the 24h circadian profile of cBP. In addition, 
the investigators have been the pioneers in comparing, si-
multaneously, ambulatory cBP changes with the diurnal 
variation of peripheral BP. For the purposes of the study, the 
investigators enrolled 171 men and women with a mean age 
of 53 years old and a history of EH. After a wash-out period, 
participants were randomized into two treatment groups re-
ceiving either a direct renin inhibitor or an angiotensin recep-
tor blocker. At the beginning and at the end of the study, 
ambulatory peripheral BP and cBP parameters were meas-
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ured using a conventional, cuff-based, oscillometric device 
(Spacelabs) and a tonometric ambulatory BP monitoring 
device (BPro) at the same time. The study demonstrated that 
cBP changes throughout the day exhibit a similar pattern of 
variability just like the diurnal fluctuation of brachial BP. 
The observed diurnal pattern of both central and peripheral 
pressure remained the same even after administration of BP 
lowering agents suggesting that BP reduction does not play a 
role in between pressure’s inter-variability. However, of ma-
jor interest was the observation that cBP levels remained 
lower than those of peripheral pressure for the whole 24h 
period whereas, and more significantly, exhibited a lower 
nocturnal dipping pattern compared to that of brachial pres-
sure [56]. Whether this phenomenon is just a normal conse-
quence of sleep or whether there are other implicating factors 
remains unknown and needs further investigation due to its 
apparent major clinical importance. Given the fact that the 
incidence of cardiovascular events is higher in non-dipper 
hypertensive individuals [26], someone could conclude that 
the less pronounced dipping profile of cBP could have a 
much more adverse impact on cardiovascular outcomes. In 
that sense, central pressure and its fluctuations could repre-
sent a new therapeutic target emphasizing the need for fur-
ther research in the field of ambulatory monitoring of cBP. 
 Another novel observation derived from the ambulatory 
monitoring of cBP, is the gradual decline of the difference 
between brachial and cSBP during the approach of night 
(with cBP falling less as mentioned above) as opposed to its 
sharp increase at the time of waking in the morning [56]. 
Until larger-scale trials come into sight, the phenomenon 
will continue to be under investigation.  
 Whereas cBP variability has started to be in the epicen-
ter of scientific interest, with the first trials coming up with 
notable, initial observations, ambulatory measurement of 
PWV continues to be a virgin field. Remarkably, no trial has 
consistently studied so far the variations of PWV throughout 
the day and as matter of fact, no correlations have been made 
between the diurnal fluctuation of PWV (if such a pattern 
exists) and the variability of peripheral or cBP. A limiting 
factor against ambulatory arterial stiffness measurement 
seems to be hydrostatic pressure. When moving from the 
supine to an upright position, hydrostatic pressure across the 
aorta increases, thereby creating a pressure gradient. Taking 
into account the fact the PWV depends heavily on arterial 
pressure, someone can conclude that variations of BP during 
postural movements could negatively affect the precise 
measurement of arterial stiffness parameters. The observed 
obstacle is one of the reasons why efforts to obtain ambula-
tory PWV measurements are still confined to a very rudi-
mental, experimental level [57, 58]. In this context, until 
more reliable methods for the ambulatory measurement of 
PWV come up, diurnal variation of arterial stiffness and its 
possible applications - implications will continue to be a 
promising field of cardiovascular research. 
CONCLUSIONS 
 Whereas peripheral BP continues to be the point of ref-
erence of all algorithms and guidelines regarding arterial 
hypertension and cardiovascular risk, it seems reasonable 
that in the very near future measurement of cBP will play a 
major role in cardiovascular risk stratification and treatment. 
 Mounting evidence from large-scale trials has demon-
strated the significance of cBP as a better marker of target 
organ damage and consequently as a more reliable predictor 
of cardiovascular morbidity and mortality. In addition, it has 
been demonstrated that antihypertensive treatment can pro-
voke different changes in cBP parameters consequently 
changing cardiovascular outcomes. These observations could 
revolutionize our therapeutic strategies making arterial stiff-
ness and cBP the primary therapeutic targets.  
 However, more research is needed before applying cBP 
parameters into every day clinical practice. The advent of 
ambulatory monitoring of cBP and probably, in the long 
term of arterial stiffness, will be a determining factor in the 
effort to understand the masked properties of central hemo-
dynamic components. With only a few trials published so 
far, it is undoubtedly a virgin field for future cardiovascular 
novelties.  
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